HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IFF Natural Ethics Ingredient Line Launches With Vanilla Offering

This article was originally published in The Rose Sheet

Executive Summary

IFF launches its Natural Ethics line of ingredients to meet demand for high-quality natural flavor and fragrance ingredients, expecting its first vanilla offering to be available next year. In the firm’s Moving Forward report, the company announces other green initiatives launched in 2012, 2013.

You may also be interested in...

Natural Marketers Discuss Ingredient-Sourcing Challenges, Greenwashing

Natural brands should cultivate a personal relationship with their suppliers while also having a backup in place to ensure against business disruptions, panelists at the Sustainable Cosmetics Summit suggested.

IFF Pursues Sustainable Ingredients Development To Drive Fragrance Biz

Partnering with Amyris, Inc. to develop sustainable fragrance ingredients is one strategy International Flavors & Fragrances is taking to boost the ingredients side of its business, which experienced an 11% sales decline in the first quarter.

IFRA Report To EC Addresses Trade Secrets, Dangers Of Full Disclosure

Safeguarding trade secrets “remains the most practical and efficient means of protecting the intangible assets” produced by innovation in the fragrance industry, IFRA asserts in a recently issued report. Threats to the industry’s intellectual property, including calls for full disclosure of formulas, put the market at risk, the group says.

Related Content

Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts